Marketing-authorisation holder
Actelion
9 medicines in 1 country, as authorisation holder.
Loadingโฆ
Marketing-authorisation holder
9 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| OPSUMIT10mg ยท Tablet | Macitentan | United States | Marketed | 2013 |
| OPSYNVI10mg; 20mg | 10mg; 40mg ยท Tablet | Macitentan, Tadalafil | United States | Marketed | 2024 |
| TRACLEER32mg ยท Tablet, for suspension | Bosentan | United States | Marketed | 2017 |
| TRACLEER125mg | 62.5mg ยท Tablet | Bosentan | United States | Marketed | 2001 |
| UPTRAVI0.2mg | 0.4mg | 0.6mg | 0.8mg | 1.2mg | 1.4mg | 1.6mg | 1mg ยท Tablet | Selexipag | United States | Marketed | 2015 |
| UPTRAVI1.8mg/vial ยท Powder | Selexipag | United States | Marketed | 2021 |
| VELETRI0.5mg base/vial | 1.5mg base/vial ยท Injectable | Epoprostenol | United States | Marketed | 2008 |
| VENTAVIS10MCG/ML (10MCG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MCG/2ML (10MCG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MCG/ML (20MCG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effec ยท Solution | Iloprost | United States | Not marketed | 2004 |
| ZAVESCA100mg ยท Capsule | Miglustat | United States | Marketed | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 9 | 9 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Actelionโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.